{
  "research_goal": {
    "id": "34d1b002",
    "title": "Novel Drug Repurposing for Acute Myeloid Leukemia",
    "description": "Identify FDA-approved drugs that could be repurposed for acute myeloid leukemia (AML) treatment. Focus on drugs that can inhibit leukemic cell proliferation at clinically applicable concentrations, particularly targeting MOLM-13 cell lines.",
    "domain": "Biomedicine/Oncology",
    "preferences": {
      "focus_on_novelty": true,
      "require_testability": true,
      "prioritize_clinical_relevance": true
    },
    "constraints": [
      "Only consider FDA-approved drugs",
      "Must have mechanism of action documentation",
      "Focus on inhibiting AML cell proliferation"
    ],
    "creation_timestamp": "2026-01-25T09:08:06.732749"
  },
  "hypotheses": [
    {
      "id": "d5279bb0",
      "title": "Hypothesis 1 (Literature-based): Biomedicine/Oncology Mechanism",
      "description": "Generated from synthesizing literature on Biomedicine/Oncology. This hypothesis proposes a novel mechanism integrating existing research.",
      "mechanism": "Building on current understanding of Biomedicine/Oncology, this mechanism suggests that the key pathway involves cross-disciplinary integration of molecular and systems-level effects.",
      "elo_rating": 1230.134205576535,
      "novelty_level": "medium",
      "status": "reviewed",
      "testable_predictions": [
        "Prediction 1: Observable effect in Biomedicine/Oncology context",
        "Prediction 2: Measurable downstream consequence",
        "Prediction 3: Quantifiable parameter change"
      ],
      "grounding_evidence": [
        "Wang et al. (2023) - Supporting pathway analysis",
        "Smith & Jones (2024) - Relevant molecular mechanism",
        "Recent meta-analysis - Contextual evidence"
      ],
      "generation_method": "initial",
      "num_reviews": 1
    },
    {
      "id": "2783c85f",
      "title": "Hypothesis 2 (Assumption-based): Novel Target in Biomedicine/Oncology",
      "description": "Generated through systematic assumption identification in Biomedicine/Oncology.",
      "mechanism": "Logical chain: If assumption X holds \u2192 intermediate effect Y \u2192 final outcome Z",
      "elo_rating": 1216.736306793522,
      "novelty_level": "medium",
      "status": "reviewed",
      "testable_predictions": [
        "Test 1: Validate foundational assumption",
        "Test 2: Measure intermediate effect",
        "Test 3: Confirm end-state outcome"
      ],
      "grounding_evidence": [
        "Logical deduction from established principles",
        "Cross-domain analytical framework"
      ],
      "generation_method": "initial",
      "num_reviews": 1
    },
    {
      "id": "515441b6",
      "title": "Hypothesis 3 (Analogy-based): Cross-domain Mechanism for Biomedicine/Oncology",
      "description": "Analogous to mechanisms in related domains, proposing novel application to Biomedicine/Oncology",
      "mechanism": "The mechanism discovered in Domain A may apply to Domain B through structural similarity",
      "elo_rating": 1211.7114294494243,
      "novelty_level": "medium",
      "status": "reviewed",
      "testable_predictions": [
        "Analogy prediction 1: Domain-specific manifestation",
        "Analogy prediction 2: Testable correspondence"
      ],
      "grounding_evidence": [],
      "generation_method": "initial",
      "num_reviews": 1
    },
    {
      "id": "18b4bdbf",
      "title": "Hypothesis 4 (Unconventional): Divergent Mechanism in Biomedicine/Oncology",
      "description": "Explores unconventional directions in Biomedicine/Oncology research",
      "mechanism": "Moving away from established paradigms to explore underexplored mechanistic space",
      "elo_rating": 1197.4317464443798,
      "novelty_level": "medium",
      "status": "reviewed",
      "testable_predictions": [
        "High-risk high-reward prediction 1",
        "Divergent experimental approach"
      ],
      "grounding_evidence": [],
      "generation_method": "initial",
      "num_reviews": 1
    },
    {
      "id": "1dc7082e",
      "title": "Hypothesis 5 (Literature-based): Biomedicine/Oncology Mechanism",
      "description": "Generated from synthesizing literature on Biomedicine/Oncology. This hypothesis proposes a novel mechanism integrating existing research.",
      "mechanism": "Building on current understanding of Biomedicine/Oncology, this mechanism suggests that the key pathway involves cross-disciplinary integration of molecular and systems-level effects.",
      "elo_rating": 1191.1268546594413,
      "novelty_level": "medium",
      "status": "reviewed",
      "testable_predictions": [
        "Prediction 1: Observable effect in Biomedicine/Oncology context",
        "Prediction 2: Measurable downstream consequence",
        "Prediction 3: Quantifiable parameter change"
      ],
      "grounding_evidence": [
        "Wang et al. (2023) - Supporting pathway analysis",
        "Smith & Jones (2024) - Relevant molecular mechanism",
        "Recent meta-analysis - Contextual evidence"
      ],
      "generation_method": "initial",
      "num_reviews": 1
    },
    {
      "id": "9663bb1d",
      "title": "Hypothesis 3 (Analogy-based): Cross-domain Mechanism for Biomedicine/Oncology (Evolved: enhancement)",
      "description": "Analogous to mechanisms in related domains, proposing novel application to Biomedicine/Oncology",
      "mechanism": "Enhanced mechanism: The mechanism discovered in Domain A may apply to Domain B through structural similarity Additionally grounded by identifying supporting molecular pathways and experimental evidence from recent literature.",
      "elo_rating": 1200.0,
      "novelty_level": "high",
      "status": "reviewed",
      "testable_predictions": [
        "Analogy prediction 1: Domain-specific manifestation",
        "Analogy prediction 2: Testable correspondence",
        "Advanced prediction: Multi-dimensional experimental validation"
      ],
      "grounding_evidence": [
        "Additional pathway analysis",
        "Cross-validation against recent meta-analyses"
      ],
      "generation_method": "evolved",
      "num_reviews": 1
    },
    {
      "id": "dfb92d87",
      "title": "Simplified: Hypothesis 2 (Assumption-based): Novel Target in Biomedicine/Oncology",
      "description": "Generated through systematic assumption identification in Biomedicine/Oncology.",
      "mechanism": "Core simplified mechanism: Logical chain: If assumption X holds \u2192 intermediate effect Y \u2192 final outcome Z. Reduces complexity by focusing on primary pathway.",
      "elo_rating": 1200.0,
      "novelty_level": "high",
      "status": "reviewed",
      "testable_predictions": [
        "Test 1: Validate foundational assumption",
        "Test 2: Measure intermediate effect"
      ],
      "grounding_evidence": [],
      "generation_method": "evolved",
      "num_reviews": 1
    },
    {
      "id": "e2b2bdea",
      "title": "Divergent: Hypothesis 4 (Unconventional): Divergent Mechanism in Biomedicine/Oncology",
      "description": "Exploring alternative mechanistic pathway divergent from: Hypothesis 4 (Unconventional): Divergent Mechanism in Biomedicine/Oncology. Considers underexplored or unconventional mechanisms.",
      "mechanism": "Alternative mechanism: Rather than the primary hypothesis, this explores secondary or tertiary pathways that may contribute to the observed phenomenon.",
      "elo_rating": 1138.3522622573284,
      "novelty_level": "high",
      "status": "reviewed",
      "testable_predictions": [],
      "grounding_evidence": [],
      "generation_method": "evolved",
      "num_reviews": 1
    },
    {
      "id": "23b68837",
      "title": "Hypothesis 2 (Assumption-based): Novel Target in Biomedicine/Oncology (Evolved: enhancement)",
      "description": "Generated through systematic assumption identification in Biomedicine/Oncology.",
      "mechanism": "Enhanced mechanism: Logical chain: If assumption X holds \u2192 intermediate effect Y \u2192 final outcome Z Additionally grounded by identifying supporting molecular pathways and experimental evidence from recent literature.",
      "elo_rating": 1214.5071948193693,
      "novelty_level": "high",
      "status": "reviewed",
      "testable_predictions": [
        "Test 1: Validate foundational assumption",
        "Test 2: Measure intermediate effect",
        "Test 3: Confirm end-state outcome",
        "Advanced prediction: Multi-dimensional experimental validation"
      ],
      "grounding_evidence": [
        "Logical deduction from established principles",
        "Cross-domain analytical framework",
        "Additional pathway analysis",
        "Cross-validation against recent meta-analyses"
      ],
      "generation_method": "evolved",
      "num_reviews": 1
    },
    {
      "id": "b4b9c811",
      "title": "Simplified: Hypothesis 1 (Literature-based): Biomedicine/Oncology Mechanism",
      "description": "Generated from synthesizing literature on Biomedicine/Oncology. This hypothesis proposes a novel mechanism integrating existing research.",
      "mechanism": "Core simplified mechanism: Building on current understanding of Biomedicine/Oncology, this mechanism suggests that the key pathway involves cross-disciplinary integration of molecular and systems-level effects. Reduces complexity by focusing on primary pathway.",
      "elo_rating": 1200.0,
      "novelty_level": "high",
      "status": "reviewed",
      "testable_predictions": [
        "Prediction 1: Observable effect in Biomedicine/Oncology context",
        "Prediction 2: Measurable downstream consequence"
      ],
      "grounding_evidence": [],
      "generation_method": "evolved",
      "num_reviews": 1
    },
    {
      "id": "0e669062",
      "title": "Divergent: Hypothesis 3 (Analogy-based): Cross-domain Mechanism for Biomedicine/Oncology",
      "description": "Exploring alternative mechanistic pathway divergent from: Hypothesis 3 (Analogy-based): Cross-domain Mechanism for Biomedicine/Oncology. Considers underexplored or unconventional mechanisms.",
      "mechanism": "Alternative mechanism: Rather than the primary hypothesis, this explores secondary or tertiary pathways that may contribute to the observed phenomenon.",
      "elo_rating": 1200.0,
      "novelty_level": "high",
      "status": "reviewed",
      "testable_predictions": [],
      "grounding_evidence": [],
      "generation_method": "evolved",
      "num_reviews": 1
    },
    {
      "id": "66984628",
      "title": "Hypothesis 1 (Literature-based): Biomedicine/Oncology Mechanism (Evolved: enhancement)",
      "description": "Generated from synthesizing literature on Biomedicine/Oncology. This hypothesis proposes a novel mechanism integrating existing research.",
      "mechanism": "Enhanced mechanism: Building on current understanding of Biomedicine/Oncology, this mechanism suggests that the key pathway involves cross-disciplinary integration of molecular and systems-level effects. Additionally grounded by identifying supporting molecular pathways and experimental evidence from recent literature.",
      "elo_rating": 1200.0,
      "novelty_level": "unknown",
      "status": "generated",
      "testable_predictions": [
        "Prediction 1: Observable effect in Biomedicine/Oncology context",
        "Prediction 2: Measurable downstream consequence",
        "Prediction 3: Quantifiable parameter change",
        "Advanced prediction: Multi-dimensional experimental validation"
      ],
      "grounding_evidence": [
        "Wang et al. (2023) - Supporting pathway analysis",
        "Smith & Jones (2024) - Relevant molecular mechanism",
        "Recent meta-analysis - Contextual evidence",
        "Additional pathway analysis",
        "Cross-validation against recent meta-analyses"
      ],
      "generation_method": "evolved",
      "num_reviews": 0
    },
    {
      "id": "5f0ce231",
      "title": "Simplified: Hypothesis 2 (Assumption-based): Novel Target in Biomedicine/Oncology",
      "description": "Generated through systematic assumption identification in Biomedicine/Oncology.",
      "mechanism": "Core simplified mechanism: Logical chain: If assumption X holds \u2192 intermediate effect Y \u2192 final outcome Z. Reduces complexity by focusing on primary pathway.",
      "elo_rating": 1200.0,
      "novelty_level": "unknown",
      "status": "generated",
      "testable_predictions": [
        "Test 1: Validate foundational assumption",
        "Test 2: Measure intermediate effect"
      ],
      "grounding_evidence": [],
      "generation_method": "evolved",
      "num_reviews": 0
    },
    {
      "id": "a221fc98",
      "title": "Divergent: Hypothesis 2 (Assumption-based): Novel Target in Biomedicine/Oncology (Evolved: enhancement)",
      "description": "Exploring alternative mechanistic pathway divergent from: Hypothesis 2 (Assumption-based): Novel Target in Biomedicine/Oncology (Evolved: enhancement). Considers underexplored or unconventional mechanisms.",
      "mechanism": "Alternative mechanism: Rather than the primary hypothesis, this explores secondary or tertiary pathways that may contribute to the observed phenomenon.",
      "elo_rating": 1200.0,
      "novelty_level": "unknown",
      "status": "generated",
      "testable_predictions": [],
      "grounding_evidence": [],
      "generation_method": "evolved",
      "num_reviews": 0
    }
  ],
  "tournament_matches": 12,
  "statistics": {
    "generation_agent": 5,
    "reflection_agent": 11,
    "ranking_agent": 12,
    "evolution_agent": 9,
    "meta_review_agent": 3
  }
}